Comparison of biochemical markers of bone turnover and bone mineral density in different groups of climacteric women

G. Morgante, A. La Marca, A. Ditto, M. C. Musacchio, C. Cavicchioli, D. Lanzetta, F. Petraglia, V. De Leo

Research output: Contribution to journalArticle

Abstract

In the present study we evaluated plasma levels of two markers of bone turnover (osteocalcin (OC) and urinary pyridinium cross-links) in association with bone mineral density (BMI) in different groups of climacteric women. We have investigated 158 women in pre-, peri,- and postmenopause. Blood and urine samples for assay of hormones and markers were collected and bone mineral density (BMD) was measured by DEXA densitometry in the distal tenth of the non-dominant forearm. There was a significant increase in mean absolute levels of both markers in perimenopause and women in natural and surgical menopause, with respect to women in premenopause. There was a significant correlation between OC and deoxypyridoline (DPYR) in peri- and postmenopause groups. In peri- and postmenopause groups, BMD was correlated with an increase in the biochemical markers of bone remodeling. In the present study, OC and DPYR were found to have good sensitivity for identifying perimenopausal women with pathological BMD. The present results reveal a positive and significant correlation between DPYR and OC, inversely proportional to BMD, during hormone replacement therapy. These markers therefore turn out to be sensitive not only for monitoring severe pathology of bone turnover, but also for monitoring slight physiological deficits in bone equilibrium beginning in perimenopause.

Original languageEnglish
Pages (from-to)466-471
Number of pages6
JournalGynecological Endocrinology
Volume15
Issue number6
Publication statusPublished - 2001

Fingerprint

Perimenopause
Bone Remodeling
Bone Density
Osteocalcin
Postmenopause
Biomarkers
Bone and Bones
Premenopause
Densitometry
Hormone Replacement Therapy
Physiologic Monitoring
Menopause
Forearm
Urine
Hormones
Pathology

Keywords

  • Bone Mineral Density
  • Hormone Replacement Therapy
  • Osteocalcin
  • Osteoporosis
  • Urinary Pyridinium Cross-links

ASJC Scopus subject areas

  • Endocrinology
  • Obstetrics and Gynaecology

Cite this

Morgante, G., La Marca, A., Ditto, A., Musacchio, M. C., Cavicchioli, C., Lanzetta, D., ... De Leo, V. (2001). Comparison of biochemical markers of bone turnover and bone mineral density in different groups of climacteric women. Gynecological Endocrinology, 15(6), 466-471.

Comparison of biochemical markers of bone turnover and bone mineral density in different groups of climacteric women. / Morgante, G.; La Marca, A.; Ditto, A.; Musacchio, M. C.; Cavicchioli, C.; Lanzetta, D.; Petraglia, F.; De Leo, V.

In: Gynecological Endocrinology, Vol. 15, No. 6, 2001, p. 466-471.

Research output: Contribution to journalArticle

Morgante, G, La Marca, A, Ditto, A, Musacchio, MC, Cavicchioli, C, Lanzetta, D, Petraglia, F & De Leo, V 2001, 'Comparison of biochemical markers of bone turnover and bone mineral density in different groups of climacteric women', Gynecological Endocrinology, vol. 15, no. 6, pp. 466-471.
Morgante, G. ; La Marca, A. ; Ditto, A. ; Musacchio, M. C. ; Cavicchioli, C. ; Lanzetta, D. ; Petraglia, F. ; De Leo, V. / Comparison of biochemical markers of bone turnover and bone mineral density in different groups of climacteric women. In: Gynecological Endocrinology. 2001 ; Vol. 15, No. 6. pp. 466-471.
@article{9b98bb5c4b4643a0acbe0ea3a692e253,
title = "Comparison of biochemical markers of bone turnover and bone mineral density in different groups of climacteric women",
abstract = "In the present study we evaluated plasma levels of two markers of bone turnover (osteocalcin (OC) and urinary pyridinium cross-links) in association with bone mineral density (BMI) in different groups of climacteric women. We have investigated 158 women in pre-, peri,- and postmenopause. Blood and urine samples for assay of hormones and markers were collected and bone mineral density (BMD) was measured by DEXA densitometry in the distal tenth of the non-dominant forearm. There was a significant increase in mean absolute levels of both markers in perimenopause and women in natural and surgical menopause, with respect to women in premenopause. There was a significant correlation between OC and deoxypyridoline (DPYR) in peri- and postmenopause groups. In peri- and postmenopause groups, BMD was correlated with an increase in the biochemical markers of bone remodeling. In the present study, OC and DPYR were found to have good sensitivity for identifying perimenopausal women with pathological BMD. The present results reveal a positive and significant correlation between DPYR and OC, inversely proportional to BMD, during hormone replacement therapy. These markers therefore turn out to be sensitive not only for monitoring severe pathology of bone turnover, but also for monitoring slight physiological deficits in bone equilibrium beginning in perimenopause.",
keywords = "Bone Mineral Density, Hormone Replacement Therapy, Osteocalcin, Osteoporosis, Urinary Pyridinium Cross-links",
author = "G. Morgante and {La Marca}, A. and A. Ditto and Musacchio, {M. C.} and C. Cavicchioli and D. Lanzetta and F. Petraglia and {De Leo}, V.",
year = "2001",
language = "English",
volume = "15",
pages = "466--471",
journal = "Gynecological Endocrinology",
issn = "0951-3590",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Comparison of biochemical markers of bone turnover and bone mineral density in different groups of climacteric women

AU - Morgante, G.

AU - La Marca, A.

AU - Ditto, A.

AU - Musacchio, M. C.

AU - Cavicchioli, C.

AU - Lanzetta, D.

AU - Petraglia, F.

AU - De Leo, V.

PY - 2001

Y1 - 2001

N2 - In the present study we evaluated plasma levels of two markers of bone turnover (osteocalcin (OC) and urinary pyridinium cross-links) in association with bone mineral density (BMI) in different groups of climacteric women. We have investigated 158 women in pre-, peri,- and postmenopause. Blood and urine samples for assay of hormones and markers were collected and bone mineral density (BMD) was measured by DEXA densitometry in the distal tenth of the non-dominant forearm. There was a significant increase in mean absolute levels of both markers in perimenopause and women in natural and surgical menopause, with respect to women in premenopause. There was a significant correlation between OC and deoxypyridoline (DPYR) in peri- and postmenopause groups. In peri- and postmenopause groups, BMD was correlated with an increase in the biochemical markers of bone remodeling. In the present study, OC and DPYR were found to have good sensitivity for identifying perimenopausal women with pathological BMD. The present results reveal a positive and significant correlation between DPYR and OC, inversely proportional to BMD, during hormone replacement therapy. These markers therefore turn out to be sensitive not only for monitoring severe pathology of bone turnover, but also for monitoring slight physiological deficits in bone equilibrium beginning in perimenopause.

AB - In the present study we evaluated plasma levels of two markers of bone turnover (osteocalcin (OC) and urinary pyridinium cross-links) in association with bone mineral density (BMI) in different groups of climacteric women. We have investigated 158 women in pre-, peri,- and postmenopause. Blood and urine samples for assay of hormones and markers were collected and bone mineral density (BMD) was measured by DEXA densitometry in the distal tenth of the non-dominant forearm. There was a significant increase in mean absolute levels of both markers in perimenopause and women in natural and surgical menopause, with respect to women in premenopause. There was a significant correlation between OC and deoxypyridoline (DPYR) in peri- and postmenopause groups. In peri- and postmenopause groups, BMD was correlated with an increase in the biochemical markers of bone remodeling. In the present study, OC and DPYR were found to have good sensitivity for identifying perimenopausal women with pathological BMD. The present results reveal a positive and significant correlation between DPYR and OC, inversely proportional to BMD, during hormone replacement therapy. These markers therefore turn out to be sensitive not only for monitoring severe pathology of bone turnover, but also for monitoring slight physiological deficits in bone equilibrium beginning in perimenopause.

KW - Bone Mineral Density

KW - Hormone Replacement Therapy

KW - Osteocalcin

KW - Osteoporosis

KW - Urinary Pyridinium Cross-links

UR - http://www.scopus.com/inward/record.url?scp=0035702394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035702394&partnerID=8YFLogxK

M3 - Article

C2 - 11826771

AN - SCOPUS:0035702394

VL - 15

SP - 466

EP - 471

JO - Gynecological Endocrinology

JF - Gynecological Endocrinology

SN - 0951-3590

IS - 6

ER -